{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:51:28Z","timestamp":1792695088967,"version":"4.5.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.clinthera.2017.03.017","type":"journal-article","created":{"date-parts":[[2017,5,3]],"date-time":"2017-05-03T00:01:26Z","timestamp":1493769686000},"page":"971-992.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Dropout Prevalence and Associated Factors in Randomized Clinical Trials of Adolescents Treated for Depression: Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"39","author":[{"given":"Adriane Isabel","family":"Rohden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Canellas","family":"Benchaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger Santos","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta\u00eds de Campos","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena M.T.","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maristela","family":"Ferigolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2017.03.017_bib1","unstructured":"World Health Organization: Adolescent Health Epidemiology. http:\/\/www.who.int\/maternal_child_adolescent\/epidemiology\/adolescence\/en\/"},{"key":"10.1016\/j.clinthera.2017.03.017_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2302\/kjm.58.95","article-title":"Suicide in adolescents: a worldwide preventable tragedy","volume":"58","author":"Greydanus","year":"2009","journal-title":"Keio J Med"},{"key":"10.1016\/j.clinthera.2017.03.017_bib3","unstructured":"World Federation for Mental Health: Depression: a global crisis. World Federation for Mental Health. http:\/\/www.who.int\/mental_health\/management\/depression\/wfmh_paper_depression_wmhd_2012.pdf"},{"key":"10.1016\/j.clinthera.2017.03.017_bib4","first-page":"1","article-title":"Programs for the prevention of suicide among adolescents and young adults; and suicide contagion and the reporting of suicide: recommendations from a national workshop","volume":"43","year":"1994","journal-title":"MMWR"},{"key":"10.1016\/j.clinthera.2017.03.017_bib5","unstructured":"World Health Organization: http:\/\/www.who.int\/maternal_child_adolescent\/epidemiology\/en\/"},{"key":"10.1016\/j.clinthera.2017.03.017_bib6","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1345\/aph.1Q020","article-title":"Factors associated with antidepressant adherence for Medicaid-enrolled children and adolescents","volume":"45","author":"Fontanella","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2017.03.017_bib7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1192\/bjp.164.5.665","article-title":"What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment","volume":"164","author":"Jonsson","year":"1994","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5380\/psi.v6i1.3193","article-title":"Depress\u00e3o na adolesc\u00eancia: caracter\u00edsticas cl\u00ednicas","volume":"6","author":"Bahls","year":"2002","journal-title":"Intera\u00e7\u00e3o em Psicologia"},{"key":"10.1016\/j.clinthera.2017.03.017_bib9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2165\/00115677-200311120-00006","article-title":"Economic impact of patient adherence with antidepressant therapy within a managed care organization","volume":"11","author":"White","year":"2003","journal-title":"Disease Management and Health Outcomes"},{"key":"10.1016\/j.clinthera.2017.03.017_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jad.2006.07.017","article-title":"Cost-of-illness studies of depression: a systematic review","volume":"98","author":"Luppa","year":"2007","journal-title":"J Affect Disord"},{"key":"10.1016\/j.clinthera.2017.03.017_bib11","first-page":"69","article-title":"Factors associated with treatment adherence in adolescents with depression","volume":"49","author":"Pacheco","year":"2011","journal-title":"Rev Chil Neuro-Psiquiat"},{"key":"10.1016\/j.clinthera.2017.03.017_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1590\/S1413-81232003000300011","article-title":"Adherence to prescribed therapy: points for concepts and presuppositions discussion","volume":"8","author":"Leite","year":"2003","journal-title":"Cien Sa\u00fade Col"},{"key":"10.1016\/j.clinthera.2017.03.017_bib13","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osteberg","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2017.03.017_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.sder.2010.03.012","article-title":"Understanding and improving treatment adherence in pediatric patients","volume":"29","author":"Huang-tz","year":"2010","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clinthera.2017.03.017_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0165-0327(84)90021-1","article-title":"Patient attrition in a comparative outcome study of depression. A follow-up report","volume":"6","author":"Simons","year":"1984","journal-title":"J Affect Disord"},{"key":"10.1016\/j.clinthera.2017.03.017_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1192\/bjp.176.2.160","article-title":"Prospective controlled study of psychiatric out-patient non-attendance: characteristics and outcome","volume":"176","author":"Killaspy","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib17","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4088\/JCP.v66n0210","article-title":"Continuity is the main challenge in treating major depressive disorder in psychiatric care","volume":"66","author":"Melartin","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.pec.2005.04.005","article-title":"Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trial","volume":"61","author":"Ekman","year":"2006","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.clinthera.2017.03.017_bib19","first-page":"264","article-title":"The PRISMA Group preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.clinthera.2017.03.017_bib20","first-page":"1","article-title":"Injection therapy for subacute and chronic low-back pain","volume":"16","author":"Staal","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2017.03.017_bib21","first-page":"1","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical","volume":"17","author":"Jadad","year":"1996","journal-title":"Trial"},{"key":"10.1016\/j.clinthera.2017.03.017_bib22","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"11","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.clinthera.2017.03.017_bib23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/sim.2934","article-title":"Recent developments in meta-analysis","volume":"28-27","author":"Sutton","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/j.clinthera.2017.03.017_bib24","doi-asserted-by":"crossref","unstructured":"Schwarzer G. General Package for Meta-analysis. 2015. https:\/\/rdrr.io\/cran\/meta\/","DOI":"10.1007\/978-3-319-21416-0_8"},{"key":"10.1016\/j.clinthera.2017.03.017_bib25","unstructured":"Viechtbauer W. Metanalysis Package for R. 2015. https:\/\/cran.r-project.org\/web\/packages\/meta\/index.html"},{"key":"10.1016\/j.clinthera.2017.03.017_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/nur.20176","article-title":"Using qualitative metasummary to synthesize and quantitative descriptive findings","volume":"30","author":"Sandelowski","year":"2007","journal-title":"Res Nurs Health"},{"key":"10.1016\/j.clinthera.2017.03.017_bib27","first-page":"12","article-title":"Efficacy of vitamin C as an adjunct to fluoxetine therapy in pediatric major depressive disorder: a randomized, double-blind, placebo-controlled pilot study","volume":"9","author":"Amr","year":"2013","journal-title":"Nutr J"},{"key":"10.1016\/j.clinthera.2017.03.017_bib28","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/cap.2006.16.59","article-title":"An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder","volume":"16","author":"Berard","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2017.03.017_bib29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00004583-200003000-00009","article-title":"Imipramine compliance in adolescents","volume":"39","author":"Bernstein","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib30","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00004583-199805000-00015","article-title":"Randomized, controlled trial of amitriptyline versus placebo for adolescents with \u201ctreatment-resistant\u201d major depression","volume":"37","author":"Birmaher","year":"1998","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00004583-200301000-00007","article-title":"paroxetine versus clomipramine in adolescents with severe major depression: a double-blind, randomized, multicenter trial","volume":"42","author":"Braconnier","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1192\/bjp.bp.107.038984","article-title":"Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression","volume":"191","author":"Byford","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/cap.2008.0001","article-title":"Maintenance study for adolescent depression","volume":"18","author":"Cheung","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2017.03.017_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/cap.2010.0006","article-title":"Anxiety as a predictor of treatment outcome in children and adolescents with depression","volume":"20","author":"Cheung","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2017.03.017_bib35","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0890-8567(09)62194-8","article-title":"A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication","volume":"44","author":"Clarke","year":"2005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib36","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.addbeh.2009.03.008","article-title":"Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder","volume":"34","author":"Cornelius","year":"2009","journal-title":"Addict Behav"},{"key":"10.1016\/j.clinthera.2017.03.017_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drugalcdep.2010.05.010","article-title":"Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults","volume":"1","author":"Cornelius","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.clinthera.2017.03.017_bib38","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cap.2013.0138","article-title":"Double-blind, placebo-controlled study of selegiline transdermal system in depressed adolescents","volume":"24","author":"DelBello","year":"2014","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2017.03.017_bib39","first-page":"1031","article-title":"A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression","volume":"54","author":"Emslie","year":"1997","journal-title":"Archives Pediatrics Adolesc Med"},{"key":"10.1016\/j.clinthera.2017.03.017_bib40","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00004583-200210000-00010","article-title":"Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial","volume":"41","author":"Emslie","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib41","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/01.chi.0000214189.73240.63","article-title":"Paroxetine treatment in children and adolescents with major depressive disorder: a randomized, multicenter, double-blind, placebo-controlled trial","volume":"45","author":"Emslie","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/chi.0b013e31802f5f03","article-title":"Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials","volume":"46","author":"Emslie","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1176\/appi.ajp.2007.07091453","article-title":"Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents","volume":"165","author":"Emslie","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib44","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1176\/appi.ajp.2010.09040552","article-title":"Treatment of Resistant Depression in Adolescents (TORDIA): week 24 outcomes","volume":"167","author":"Emslie","year":"2010","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib45","first-page":"170","article-title":"A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder","volume":"24","author":"Emslie","year":"2014","journal-title":"J\u00a0Child\u00a0Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2017.03.017_bib46","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1089\/cap.2012.0023","article-title":"Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial","volume":"23","author":"Findling","year":"2013","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2017.03.017_bib47","first-page":"85","article-title":"Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a \u201cfixed plasma level\u201d design","volume":"26","author":"Geller","year":"1990","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.clinthera.2017.03.017_bib48","first-page":"1","article-title":"Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial","volume":"335","author":"Goodbyer","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2017.03.017_bib49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/cap.2006.16.207","article-title":"Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study","volume":"16","author":"Heiligenstein","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2017.03.017_bib50","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jsat.2011.09.010","article-title":"Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders","volume":"42","author":"Hirschtritt","year":"2012","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.clinthera.2017.03.017_bib51","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0893-133X(00)00098-1","article-title":"Clinician, parent, and child prediction of medication or placebo in double-blind depression study","volume":"23","author":"Hughes","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clinthera.2017.03.017_bib52","first-page":"687","article-title":"Rational-emotive and cognitive-behavior therapy (REBT\/CBT) versus pharmacotherapy versus REBT\/CBT plus pharmacotherapy in the treatment of major depressive disorder in youth; a randomized clinical trial","volume":"225","author":"Iftene","year":"2014","journal-title":"Psychiatry\u00a0Res"},{"key":"10.1016\/j.clinthera.2017.03.017_bib53","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/00004583-200107000-00010","article-title":"Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial","volume":"40","author":"Keller","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib54","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/CHI.0b013e31818914a1","article-title":"Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder","volume":"47","author":"Kennard","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib55","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1176\/appi.ajp.2014.13111460","article-title":"Sequential treatment with fluoxetine and relapse\u2014prevention CBT to improve outcomes in pediatric depression","volume":"171","author":"Kennard","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib56","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/(SICI)1520-6394(1998)7:1<15::AID-DA3>3.0.CO;2-4","article-title":"Adolescent depression: controlled desipramine treatment and atypical features","volume":"7","author":"Klein","year":"1998","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.clinthera.2017.03.017_bib57","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00004583-199406000-00010","article-title":"Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial","volume":"33","author":"Kutcher","year":"1994","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib58","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/00004583-199609000-00011","article-title":"A randomized, controlled trial of amitriptyline in the acute treatment of adolescent major depression","volume":"35","author":"Kye","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib59","first-page":"149","article-title":"Venlafaxine in the treatment of children and adolescents with major depression","volume":"33","author":"Mandoki","year":"1997","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.clinthera.2017.03.017_bib60","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archpsyc.64.10.1132","article-title":"The Treatment for Adolescents with Depression Study (TADS): long-term effectiveness and safety outcomes","volume":"64","author":"March","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib61","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1017\/S1092852900020666","article-title":"Do children and adolescents have differential response rates in placebo-controlled trials of fluoxetine?","volume":"12","author":"Mayes","year":"2007","journal-title":"CNS Spectr"},{"key":"10.1016\/j.clinthera.2017.03.017_bib62","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/01.chi.0000233157.21925.71","article-title":"A comparison of cognitive-behavioral therapy, sertraline, and their combination for adolescent depression","volume":"45","author":"Melvin","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib63","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1001\/archpedi.161.11.1026","article-title":"A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders","volume":"161","author":"Riggs","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.clinthera.2017.03.017_bib64","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-0327(96)00084-5","article-title":"The effects of extended evaluation on depressive symptoms in children and adolescents","volume":"41","author":"Rintelmann","year":"1996","journal-title":"J Affect Disord"},{"key":"10.1016\/j.clinthera.2017.03.017_bib65","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/archpsyc.65.4.447","article-title":"Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy","volume":"65","author":"Rohde","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib66","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/cap.2006.16.103","article-title":"Long-term sertraline treatment of children and adolescents with major depressive disorder","volume":"16","author":"Rynn","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2017.03.017_bib67","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1176\/ajp.154.5.668","article-title":"Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial","volume":"154","author":"Sallee","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib68","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0278-5846(90)90050-Q","article-title":"Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up","volume":"14","author":"Simeon","year":"1990","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib69","first-page":"109","article-title":"Sertraline in adolescents with major depressive disorder: results from a prospective, randomized, open study","volume":"11","author":"Teodorescu","year":"2011","journal-title":"Romanian J Psychopharmacol"},{"key":"10.1016\/j.clinthera.2017.03.017_bib70","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/CHI.0b013e3181b5db66","article-title":"Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters Study (TASA)","volume":"48","author":"Vitiello","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib71","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/01.jcp.0000219051.40632.d5","article-title":"A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder","volume":"26","author":"von Knorring","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2017.03.017_bib72","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.290.8.1033","article-title":"efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials","volume":"290","author":"Wagner","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2017.03.017_bib73","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1176\/appi.ajp.161.6.1079","article-title":"A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents","volume":"161","author":"Wagner","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib74","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.chi.0000192250.38400.9e","article-title":"A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression","volume":"45","author":"Wagner","year":"2006","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib75","first-page":"1","article-title":"The effects of cognitive-behavioural therapy on mood-related ruminative response style in depressed adolescents","author":"Wilkinson","year":"2008","journal-title":"Child Adolesc Psychiatry Men Health"},{"key":"10.1016\/j.clinthera.2017.03.017_bib76","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1192\/bjp.bp.108.052381","article-title":"Treated depression in adolescents: predictors of outcome at 28 weeks","volume":"194","author":"Wilkinson","year":"2009","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib77","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.euroneuro.2007.06.001","article-title":"Randomised controlled trials of selective serotonin reuptake inhibitors in treating depression in children and adolescents: a systematic review and meta-analysis","volume":"18","author":"Usala","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.clinthera.2017.03.017_bib78","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1136\/bmj.310.6992.1433","article-title":"Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis","volume":"310","author":"Anderson","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2017.03.017_bib79","first-page":"243","article-title":"Utilization patterns of antidepressant medications in a patient population served by a primary care medical group","volume":"5","author":"Venturini","year":"1999","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.clinthera.2017.03.017_bib80","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/1097-0258(20010115)20:1<93::AID-SIM655>3.0.CO;2-2","article-title":"Adjusting for drop-out in clinical trials with repeated measures: design and analysis trials issues","volume":"20","author":"Wu","year":"2001","journal-title":"Stat Med"},{"key":"10.1016\/j.clinthera.2017.03.017_bib81","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.160.14.2101","article-title":"Depression is a risk factor for noncompliance with medical treatment","volume":"160","author":"Dimatteo","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2017.03.017_bib82","first-page":"150","article-title":"Fundamental of Clinical Psychopharmacology. Ed. 2\u00aa","author":"Dunitz","year":"2004","journal-title":"Editor Taylor & Francis. Londres"},{"key":"10.1016\/j.clinthera.2017.03.017_bib83","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/archpsyc.63.3.332","article-title":"Suicidality in pediatric patients treated with antidepressant drugs","volume":"63","author":"Hammad","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib84","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/dev.20447","article-title":"The storm and stress of adolescence: insights from human imaging and mouse genetics","volume":"52","author":"Casey","year":"2010","journal-title":"Devl Psychobiol"},{"key":"10.1016\/j.clinthera.2017.03.017_bib85","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0893-133X(00)00227-X","article-title":"Serotonin 5-HT1A receptor binding potential declines with age as measured by [11C]WAY-100635 and PET","volume":"24","author":"Tauscher","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clinthera.2017.03.017_bib86","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1038\/npp.2011.163","article-title":"Age, sex, and reproductive hormone effects on brain serotonin-1A and serotonin-2A receptor binding in a healthy population","volume":"36","author":"Moses-Kolko","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clinthera.2017.03.017_bib87","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jamapsychiatry.2014.2406","article-title":"Positron emission tomography quantification of serotonin (1A) receptor binding in suicide attempters with major depressive disorder","volume":"72","author":"Sullivan","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib88","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00004583-200209000-00003","article-title":"Sertraline pharmacokinetics and dynamics in adolescents","volume":"41","author":"Axelson","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatric"},{"key":"10.1016\/j.clinthera.2017.03.017_bib89","first-page":"1","article-title":"Suicidality and aggression during antidepressant treatment: systematic review and meta-analysis based on clinical study reports","volume":"352","author":"Sharma","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2017.03.017_bib90","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/archgenpsychiatry.2011.2048","article-title":"Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine","volume":"69","author":"Gibbons","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib91","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1600-0447.2009.01514.x","article-title":"Mania associated with antidepressant treatment: comprehensive meta-analytic review","volume":"121","author":"Tondo","year":"2010","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.clinthera.2017.03.017_bib92","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1089\/cap.2013.0146","article-title":"A double-blind efficacy and safety study of duloxetine flexible dosing in children and adolescents with major depressive disorder","volume":"24","author":"Atkinson","year":"2014","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2017.03.017_bib93","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2217\/14796708.4.1.87","article-title":"Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors","volume":"4","author":"Joseph","year":"2009","journal-title":"Future Neurol"},{"key":"10.1016\/j.clinthera.2017.03.017_bib94","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archpedi.159.3.298-a","article-title":"Risk of mania with antidepressants. Arch Pediatric","volume":"159","author":"Baldessarini","year":"2005","journal-title":"Adolesc Med"},{"key":"10.1016\/j.clinthera.2017.03.017_bib95","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5114\/pdia.2014.40930","article-title":"Severe skin complications in patients treated with antidepressants: a literature review","volume":"2","author":"Herstowska","year":"2014","journal-title":"Post\u0119py Dermatologii i Alergologii"},{"key":"10.1016\/j.clinthera.2017.03.017_bib96","first-page":"1642","article-title":"Antidepressant-associated mania: a controlled comparison with spontaneous mania","volume":"51","author":"Stoll","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib97","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.clinthera.2011.11.024","article-title":"Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study","volume":"34","author":"Anderson","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2017.03.017_bib98","first-page":"233","article-title":"Pharmacological treatment of depression","volume":"205","author":"Ruiz","year":"2005","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.clinthera.2017.03.017_bib99","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1310\/hct0704-203","article-title":"Tutorial reduces protocol deviations in multicenter ACTG trials with pharmacology endpoints","volume":"7","author":"Difrancesco","year":"2006","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.clinthera.2017.03.017_bib100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.mppsy.2007.04.005","article-title":"Antidepressants","volume":"6","author":"Nash","year":"2007","journal-title":"Psychiatry"},{"key":"10.1016\/j.clinthera.2017.03.017_bib101","unstructured":"Bonin L, Brent D, Solomon D. Depression in children and adolescents (Beyond the Basics). http:\/\/www.uptodate.com\/contents\/depression-in-children-and-adolescents-beyond-the-basics. Accessed November 20, 2016."},{"key":"10.1016\/j.clinthera.2017.03.017_bib102","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jpeds.2015.05.049","article-title":"Parents role in adolescent depression care: primary care provider perspectives","volume":"167","author":"Radovic","year":"2015","journal-title":"J Pediatrics"},{"key":"10.1016\/j.clinthera.2017.03.017_bib103","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/pch\/13.1.19","article-title":"Adherence to treatment in adolescents","volume":"13","author":"Taddeo","year":"2008","journal-title":"Pediatric Child Health"},{"key":"10.1016\/j.clinthera.2017.03.017_bib104","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1542\/peds.2006-1395","article-title":"Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and ongoing management","volume":"120","author":"Cheung","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2017.03.017_bib105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1590\/S1413-81232010000200018","article-title":"Prevalence and factors associated with the adhesion of children in highly active antiretroviral therapy in three urban centers in Southern Brazil","volume":"15","author":"Trombini","year":"2010","journal-title":"Cien Saude Colet"},{"key":"10.1016\/j.clinthera.2017.03.017_bib106","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00228-014-1803-x","article-title":"Prescription and indication trends of antidepressant drugs in the Netherlands between 1996 and 2012: a dynamic population-based study","volume":"71","author":"Noordam","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2017.03.017_bib107","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.clinthera.2009.07.002","volume":"31","author":"Skaer","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2017.03.017_bib108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0033181","article-title":"Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in the Health Improvement Network (THIN)","volume":"7","author":"Wijlaars","year":"2012","journal-title":"Plos One"},{"key":"10.1016\/j.clinthera.2017.03.017_bib109","doi-asserted-by":"crossref","first-page":"743","DOI":"10.7326\/0003-4819-132-9-200005020-00011","article-title":"A systematic review of newer pharmacotherapies for depression in adults: evidence report summary","volume":"132","author":"Williams","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2017.03.017_bib110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/(SICI)1520-6394(1997)6:1<10::AID-DA2>3.0.CO;2-9","article-title":"Are SSRIs better than TCAs? Comparison of SSRIs and TCAs: a meta-analysis","volume":"6","author":"Steffens","year":"1997","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.clinthera.2017.03.017_bib111","doi-asserted-by":"crossref","first-page":"478","DOI":"10.20452\/pamw.743","article-title":"First-line pharmacotherapies for depression\u2014what is the best choice?","volume":"119","author":"Koenig","year":"2009","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/j.clinthera.2017.03.017_bib112","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(12)61552-9","article-title":"Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial","volume":"381","author":"Wiles","year":"2012","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2017.03.017_bib113","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jad.2009.06.042","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication","volume":"117","author":"Parikh","year":"2009","journal-title":"J Affec Disord"},{"key":"10.1016\/j.clinthera.2017.03.017_bib114","series-title":"Cognitive Models of Depression. In: Clinical Advances in Cognitive Psychotherapy: Theory and Application","first-page":"29","author":"Beck","year":"2002"},{"key":"10.1016\/j.clinthera.2017.03.017_bib115","series-title":"Cognitive therapy for severe mental disorders. In: Seminars in the Psychotherapies","first-page":"178","author":"Scott","year":"2007"},{"key":"10.1016\/j.clinthera.2017.03.017_bib116","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1037\/a0021175","article-title":"Dropout and therapeutic alliance: a meta-analysis of adult individual psychotherapy","volume":"47","author":"Sharf","year":"2010","journal-title":"Psychotherapy"},{"key":"10.1016\/j.clinthera.2017.03.017_bib117","first-page":"32","article-title":"Comorbid adolescent substance use and major depressive disorders: a review","volume":"4","author":"Kaminer","year":"2007","journal-title":"Psychiatry"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817301996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291817301996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T03:31:21Z","timestamp":1750217481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291817301996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":117,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0149291817301996"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.03.017","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dropout Prevalence and Associated Factors in Randomized Clinical Trials of Adolescents Treated for Depression: Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2017.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}